Recall | Veterinary Medicines | 26/07/2016

The marketing authorization holder has informed its supplied customers that a recall of all batches of "Velactis" on the market will be carried out, as serious side effects have been reported since market launch. The Scientific Committee for Medicinal Products for Veterinary Use of the European Medicines Agency (EMA) has therefore decided to recommend to the European Commission that the marketing authorization be suspended.

Name of the medicinal product Velactis 1,12 mg/ml Injektionslösung für Rinder
Marketing authorisation number(s) EU/2/15/192/001-004
Marketing authorisation holder Ceva Santé Animale
Batch number(s) 106A3, 107A2
Classification of the recallNicht anwendar (Rückruf aufgrund von schwerwiegenden Nebenwirkungen)
BASG reference number INS-640.001-1783
Safety warnings Link
Further information Link

Further inquiry note